Luminist Labs

Liver fibrosis and NASH are often detected late because existing diagnostics can be invasive or insufficient for early staging.

A non-invasive diagnostic test platform for early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH).

Clinicians and healthcare providers (e.g., hospitals and specialty liver clinics) diagnosing and monitoring patients at risk for liver disease.